Emily Oplinger
About Emily Oplinger
Emily Oplinger is a Cell Therapy Specialist III and Team Lead at BioNTech SE, with extensive experience in the field of cell therapy. She has worked at Kite Pharma and previously at Eurofins Lancaster Laboratories, holding various roles since 2015.
Work at Kite Pharma
Emily Oplinger has been employed at Kite Pharma since 2018, where she has held various positions related to cell therapy. Initially, she worked as a Cell Therapy Specialist II, focusing on Clinical Neoantigen from 2019. In 2021, she advanced to the role of Cell Therapy Specialist III and Team Lead. Her work at Kite Pharma is based in Gaithersburg, Maryland, where she has contributed to the development and implementation of cell therapy solutions.
Previous Experience at Eurofins Lancaster Laboratories
Prior to her tenure at Kite Pharma, Emily Oplinger worked as a Scientist at Eurofins Lancaster Laboratories from 2015 to 2018. During her three years in Lancaster, Pennsylvania, she gained valuable experience in laboratory settings, focusing on scientific research and development. This role provided her with a strong foundation in scientific methodologies and practices.
Education and Expertise
Emily Oplinger earned her Bachelor of Science (B.S.) degree in Biology from Penn State University, where she studied from 2011 to 2015. Her educational background has equipped her with a solid understanding of biological sciences, which she applies in her current roles in cell therapy. Her expertise encompasses various aspects of cell therapy, including clinical applications and team leadership.